Your browser doesn't support javascript.
loading
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis.
Mangiacavalli, Silvia; Cartia, Claudio Salvatore; Galli, Monica; Pezzatti, Sara; Belotti, Angelo; Fazio, Francesca; Mina, Roberto; Marcatti, Magda; Cafro, Anna; Zambello, Renato; Paris, Laura; Barilà, Gregorio; Olivares, Cecilia; Pompa, Alessandra; Mazza, Rita; Farina, Francesca; Soldarini, Martina; Benvenuti, Pietro; Pagani, Giuseppina; Palumbo, Michele; Masoni, Valeria; Ferretti, Virginia Valeria; Klersy, Catherine; Arcaini, Luca; Petrucci, Maria Teresa.
Afiliação
  • Mangiacavalli S; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia. s.mangiacavalli@smatteo.pv.it.
  • Cartia CS; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia.
  • Galli M; Division of Hematology, ASST Papa Giovanni XXIII, Bergamo.
  • Pezzatti S; Division of Hematology, San Gerardo Hospital, Monza.
  • Belotti A; Division of Hematology, A.O. Spedali Civili, Brescia.
  • Fazio F; Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome.
  • Mina R; SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino.
  • Marcatti M; Division of Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan.
  • Cafro A; Hematology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan.
  • Zambello R; Hematology and Clinical Immunology, Department of Medicine, Azienda Ospedaliera di Padova, Padova.
  • Paris L; Division of Hematology, ASST Papa Giovanni XXIII, Bergamo.
  • Barilà G; University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padova.
  • Olivares C; Division of Hematology, Ospedale di Circolo and Fondazione Macchi, University of Insubria, Varese.
  • Pompa A; Division of Hematology and Stem Cell Transplantation, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico, Milan.
  • Mazza R; Humanitas Clinical and Research Center, IRCCS, Milan.
  • Farina F; Division of Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan.
  • Soldarini M; Hematology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan.
  • Benvenuti P; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia.
  • Pagani G; Department of Molecular Medicine, University of Pavia, Pavia.
  • Palumbo M; Department of Molecular Medicine, University of Pavia, Pavia.
  • Masoni V; Department of Molecular Medicine, University of Pavia, Pavia.
  • Ferretti VV; Clinical Epidemiology and Biostatistics Service, Fondazione IRCCS Policlinico San Matteo, Pavia.
  • Klersy C; Clinical Epidemiology and Biostatistics Service, Fondazione IRCCS Policlinico San Matteo, Pavia.
  • Arcaini L; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Pavia.
  • Petrucci MT; Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome.
Haematologica ; 108(3): 833-842, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36200419

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article